✦ LIBER ✦

Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy

✍ Scribed by N. S. FERDER; C. S. EBY; E. DEYCH; J. K. HARRIS; P. M. RIDKER; P. E. MILLIGAN; S. Z. GOLDHABER; C. R. KING; T. GIRI; H. L. MCLEOD; R. J. GLYNN; B. F. GAGE

Book ID: 109153157
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 154 KB
Volume: 8
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2009.03677.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicting the warfarin maintenance dose

Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypes

✍ C. MOREAU; E. PAUTAS; I. GOUIN-THIBAULT; J.-L. GOLMARD; I. MAHÉ; C. MULOT; M.-A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Contribution of VKORC1 and CYP2C9 polymo

Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations

✍ Gin Gin Gan; Maude E. Phipps; Michael M. T. Lee; Liang S. Lu; Rajallectchumy Y. 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 140 KB

Contribution of age, body weight, and CY

Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients

✍ Liyan Miao; Jian Yang; Chenrong Huang; Zhenya Shen 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 166 KB